Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Kramer

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Pediatric Blood & Cancer|August 27, 2005
Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patientsBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Journal of Pediatric Hematology/Oncology|November 16, 2004
Favorable-biology neuroblastoma presenting with leptomeningeal metastases?: a case presentationKim Kramer, Brian H Kushner, Jeffrey C Allen, et al.
Pediatric Blood & Cancer|June 24, 2008
Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomideBrian H Kushner, Michael P Laquaglia, Kim Kramer, et al.
Cancer|June 22, 2010
Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Blood & Cancer|January 20, 2006
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapyBrian H Kushner, Irene Y Cheung, Kim Kramer, et al.
Medical and Pediatric Oncology|November 5, 2003
Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experienceBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2008
Management and outcome of stage 3 neuroblastomaShakeel Modak, Brian H Kushner, Michael P LaQuaglia, et al.
Pediatric Blood & Cancer|April 14, 2005
Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopeniaJames B Bussel, Stergios Zacharoulis, Kim Kramer, et al.
Pediatric Blood & Cancer|December 31, 2013
Marker (+) CNS germ cell tumors in remission: are surveillance MRI scans necessary?Sybila Martinez, Yasmin Khakoo, Stephen Gilheeney, et al.
Journal of Pediatric Hematology/Oncology|September 25, 2013
A case of mannitol hypersensitivityDonita D Lightner, Kevin De Braganca, Stephen W Gilheeney, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Pediatric Blood & Cancer|August 27, 2005
Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patientsBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Journal of Pediatric Hematology/Oncology|November 16, 2004
Favorable-biology neuroblastoma presenting with leptomeningeal metastases?: a case presentationKim Kramer, Brian H Kushner, Jeffrey C Allen, et al.
Pediatric Blood & Cancer|June 24, 2008
Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomideBrian H Kushner, Michael P Laquaglia, Kim Kramer, et al.
Cancer|June 22, 2010
Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Blood & Cancer|January 20, 2006
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapyBrian H Kushner, Irene Y Cheung, Kim Kramer, et al.
Medical and Pediatric Oncology|November 5, 2003
Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experienceBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2008
Management and outcome of stage 3 neuroblastomaShakeel Modak, Brian H Kushner, Michael P LaQuaglia, et al.
Pediatric Blood & Cancer|April 14, 2005
Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopeniaJames B Bussel, Stergios Zacharoulis, Kim Kramer, et al.
Pediatric Blood & Cancer|December 31, 2013
Marker (+) CNS germ cell tumors in remission: are surveillance MRI scans necessary?Sybila Martinez, Yasmin Khakoo, Stephen Gilheeney, et al.
Journal of Pediatric Hematology/Oncology|September 25, 2013
A case of mannitol hypersensitivityDonita D Lightner, Kevin De Braganca, Stephen W Gilheeney, et al.
Pageof 11